Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial-Reference-Cited by-同舟云学术

Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial

Published:2019-11-01 Issue:3 Volume:82 Page:321-328
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Kityo Cissy,Hagins Debbie,Koenig Ellen,Avihingsanon Anchalee,Chetchotisakd Ploenchan,Supparatpinyo Khuanchai,Gankina Natalya,Pokrovsky Vadim,Voronin Evgeny,Stephens Jeffrey L.,DeJesus Edwin,Wang Hui,Acosta Rima K.,Cao Huyen,Quirk Erin,Martin Hal,Makadzange Tariro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference27 articles.

1. Women's involvement in clinical trials: historical perspective and future implications;Liu;Pharm Pract (Granada).,2016

2. A systematic review of the inclusion (or exclusion) of women in HIV research: from clinical studies of antiretrovirals and vaccines to cure strategies;Curno;J Acquir Immune Defic Syndr.,2016

3. Does patient sex affect human immunodeficiency virus levels?;Gandhi;Clin Infect Dis.,2002

4. Gender differences in mortality and CD4 count response among virally suppressed HIV-positive patients;Maskew;J Womens Health (Larchmt).,2013

5. Gender differences in pharmacological response;Anderson;Int Rev Neurobiol.,2008

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in HIV Management During Pregnancy and Infant Feeding;Infectious Disease Clinics of North America;2024-09

2. B/F/TAF forgiveness to non-adherence;Sexually Transmitted Infections;2024-07-04

3. Rates of adverse events of antiretroviral therapy in women living with HIV/AIDS: a systematic review and meta-analysis;BMJ Open;2024-07

4. Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV from the Canadian cohort of the observational BICSTaR study;Medicine;2024-04-19

5. Distinct Lipidomic Profiles between People Living with HIV Treated with E/C/F/TAF or B/F/TAF: An Open-Label Prospective Cohort Study;Infectious Diseases and Therapy;2024-03-15